NCT02745938View on ClinicalTrials.gov

GDF-15 as a Biomarker for Mitochondrial Disease

CompletedOBSERVATIONAL
Enrollment

97

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Mitochondrial DiseaseMetabolic MyopathyMuscular Dystrophy
Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT02745938 - GDF-15 as a Biomarker for Mitochondrial Disease | Biotech Hunter | Biotech Hunter